Topics: Antipsychotics

You’ve probably heard about Fanapta (iloperidone), a new antipsychotic marketed by Vanda Pharmaceuticals. No, it hasn’t been approved officially yet, but it is likely to win approval in July, and the company has already been taking out teaser ads in the journals and has even sponsored a touring promotional CME program run by Stephen Stahl.

Topics: Antipsychotics

Here is some selective coverage of interesting recent developments in antipsychotic medications.

A non-profit agency called the Institute for Safe Medication Practices (ISMP) has released an analysis of the side effects of Chantix (varenicline), and the news is not good.

Topics: Bipolar Disorder

How should we treat patients with both bipolar disorder and a comorbid anxiety disorder? The answer is not straightforward.

Topics: Antipsychotics

The first antipsychotic medication was discovered by a French naval surgeon named Henri Laborit. Dr. Laborit had little interest in psychiatry, but was avidly seeking a way to better treat wounded soldiers who were in shock.

Topics: Antipsychotics

Dr. Jibson, there have been several meta-analyses comparing atypical antipsychotics published over the last few years. They are all long, complicated papers, and the conclusions are often controversial. Can you help us understand this literature?